The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity
Sabelo Lukhele(University Health Network), David G. Brooks(University Health Network), Rene Quevedo(University Health Network), Bryan E. Snow(University Health Network), Weiguo Cui(Medical College of Wisconsin), Jillian Haight(University Health Network), Andrew Wakeham(Ontario Institute for Cancer Research), Laura M. Snell(Indiana University School of Medicine), Ramy Gadalla(University Health Network), Madeleine Carew(University Health Network), Heidi Elsaesser(University Health Network), Pamela S. Ohashi(University Health Network), Jian Shen(Medical College of Wisconsin), Tracy L. McGaha(Centre for Disability Prevention and Rehabilitation), Diala Abd Rabbo(University Health Network), Mengdi Guo(University Health Network), Marion Ciudad(University Health Network), Lawanya Mahesh(University Health Network), Annick You-Ten(Ontario Institute for Cancer Research), Tak W. Mak(University Health Network)
Cited by 140
Related Papers
Regulation of tumour necrosis factor signalling: live or let die
|Nature reviews. Immunology|2015|994
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
|Genes & Development|1998|841
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803